Literature DB >> 35854082

Should the Revised Uniform Determination of Death Act Address Objections to the Use of Neurologic Criteria to Declare Death?

Ariane Lewis1.   

Abstract

In response to concerns about the declaration of death by neurologic criteria, the Uniform Law Commission created a drafting committee to update the Uniform Determination of Death Act (UDDA) in the Fall of 2021. One of the key questions for the committee to address was the following: Should the revised UDDA address objections to the use of neurologic criteria to declare death? This article (1) provides historical background and survey results that demonstrate the need to address this question; (2) summarizes the ethical principles that support and oppose accommodation of objections to the use of neurologic criteria to declare death; (3) reviews accommodation in other areas of medicine and law; (4) discusses existing legal and hospital guidance on management of these objections; (5) examines perspectives of stakeholder medical societies and expert health care professionals, lawyers, ethicists, and philosophers on whether the revised UDDA should address these objections; (6) identifies some questions for the drafting committee to consider when deciding whether the revised UDDA should address objections to the use of neurologic criteria to declare death; and (7) summarizes the potential downstream effects of the drafting committee's decision.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Entities:  

Keywords:  Accommodation; Brain death; Ethics; Medicolegal; Religion; Uniform Determination of Death Act

Mesh:

Year:  2022        PMID: 35854082     DOI: 10.1007/s12028-022-01567-3

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.532


  1 in total

1.  Family members' requests to extend physiologic support after declaration of brain death: a case series analysis and proposed guidelines for clinical management.

Authors:  Anne Lederman Flamm; Martin L Smith; Patricia A Mayer
Journal:  J Clin Ethics       Date:  2014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.